Velders, Aldrik H <br/><br/>
Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).  [electronic resource] 

 -  Journal of medicinal chemistry  Feb 2004 
 - 1110-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm030984d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--chemical synthesis<br/>Cell Cycle--drug effects<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Crystallography, X-Ray<br/>Drug Screening Assays, Antitumor<br/>Hydrolysis<br/>Kidney--drug effects<br/>Liver--drug effects<br/>Lung Neoplasms--drug therapy<br/>Magnetic Resonance Spectroscopy<br/>Mammary Neoplasms, Animal--pathology<br/>Matrix Metalloproteinase 9--chemistry<br/>Mice<br/>Molecular Structure<br/>Neoplasm Invasiveness<br/>Neoplasm Metastasis--prevention & control<br/>Organometallic Compounds--chemical synthesis<br/>Ruthenium--pharmacokinetics<br/>Spectrophotometry, Ultraviolet<br/>Structure-Activity Relationship<br/>Tissue Distribution